USRE33778EExpiredUtility
1,3-dithietane-2-carboxylic acid penicillin and cephalosporin derivatives
Priority: Jul 28, 1977Filed: Dec 8, 1989Granted: Dec 24, 1991
Est. expiryJul 28, 1997(expired)· nominal 20-yr term from priority
C07D 339/00
54
PatentIndex Score
15
Cited by
3
References
1
Claims
Abstract
Substituted 1,3-dithietane-2-carboxylic acid derivatives useful as intermediates for the preparation of highly effective penicillin and cephalosporin derivatives and the preparation thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is: .[.1. 7-substituted cephalosporin or penicillin derivatives represented by the formula ##STR79## wherein R 1 is a carboxyl group or the functional derivative residue thereof selected from the group consisting of carboxylic acid lower alkyl ester residue, carboxylic acid aralkyl ester residue, a carbamoyl group, N-monoalkylcarbamoyl group, N,N-dialkylcarbamoyl group, a carboazoyl group, and a cyano group; R 2 is a carboxyl group or the functional derivative residue thereof selected from the group consisting of carboxylic acid lower alkyl ester residue, carboxylic acid aralkyl ester residue, a carbamoyl group, N-monoalkylcarbamoyl group, N,N-dialkylcarbamoyl group, a carboazoyl group, and a cyano group, a hydrogen atom, a lower alkyl group, a lower hydroxyalkyl group, a lower alkoxyalkyl group, a lower carboxyalkyl group, a lower arylalkyl group, a lower alkoxy group, a lower alkanoyl group, R 4 S(O) n group wherein R 4 represents a lower alkyl group and n represents 0, 1 or 2, and aryl group which may have a substituted selected from the group consisting of hydroxyl and alkoxy groups, an aroyl group, a lower alkenyl group, a sulfamoyl group, or a heterocyclic residue which may have a substituent selected from the group consisting of a hydroxyl group, methyl group, and alkylthio group; and wherein ○Ce and ○Pe represent a cephalosporin nucleus and a penicillin nucleus,
respectively..]. .Iadd.2. 6-substituted penicillin derivative represented by the formula ##STR80## wherein R 1 is a carboxyl group or the functional derivative residue thereof selected from the group consisting of carboxylic acid lower alkyl ester residue, carboxylic acid aralkyl ester residue, a carbamoyl group, N-monoalkylcarbamoyl group, N,N-dialkylcarbamoyl group, a carboazoyl group, and a cyano group; R 2 is a carboxyl group or the functional derivative residue thereof selected from the group consisting of carboxylic acid lower alkyl ester residue, carboxylic acid aralkyl ester residue, a carbamoyl group, N-monoalkylcarbamoyl group, N,N-dialkylcarbamoyl group, a carboazoyl group, and a cyano group, a hydrogen atom, a lower alkyl group, a lower hydroxyalkyl group, a lower alkoxyalkyl group, a lower carboxyalkyl group, a lower aralkyl group, a lower alkoxy group, a lower alkanoyl group, R 4 S(O) n group wherein R 4 represents a lower alkyl group and n represents 0, 1 or 2, and aryl group which may have a substituent selected from the group consisting of hydroxyl and alkoxy groups, an aroyl group, a lower alkenyl group, a sulfamoyl group, or a heterocyclic residue which may have a substituent selected from the group consisting of a hydroxyl group, methyl group, and alkylthio group; and wherein ○Pe represents a
penicillin nucleus. .Iaddend. .Iadd.3. The 6-substituted penicillin derivative of claim 2 wherein R 1 and R 2 are each a carboxyl group. .Iaddend. .Iadd.4. The 6-substituted penicillin derivative of claim 2 wherein R 1 is a carboxyl group and R 2 is a lower alkylthio group. .Iaddend. .Iadd.5. The 6-substituted penicillin derivative of claim 2 wherein R 1 is a carboxyl group and R 2 is a lower alkoxy group. .Iaddend. .Iadd.6. The 6-substituted penicillin derivative of claim 2 wherein R 1 is a carboxyl group and R 2 is a lower alkyl group. .Iaddend. .Iadd.7. The 6-substituted penicillin derivative of claim 2 wherein R 1 is a carboxyl group and R 2 is hydrogen. .Iaddend. .Iadd.8. 7-substituted cephalosporin derivative represented by the formula ##STR81## wherein R 1 is an N-monoalkylcarbamoyl group or an N,N-dialkylcarbamoyl group; R 2 is a carboxyl group or the functional derivative residue thereof selected from the group consisting of carboxylic acid lower alkyl ester residue, carboxylic acid aralkyl ester residue, a carbamoyl group, N-monoalkylcarbamoyl group, N,N-dialkylcarbamoyl group, a carboazoyl group, and a cyano group, a hydrogen atom, a lower alkyl group, a lower hydroxyalkyl group, a lower alkoxyalkyl group, a lower carboxyalkyl group, a lower arylalkyl group, a lower alkoxy group, a lower alkanoyl group, R 4 S(O) n group wherein R 4 represents a lower alkyl group and n represents 0, 1 or 2, and aryl group which may have a substituent selected from the group consisting of hydroxyl and alkoxy groups, an aroyl group, a lower alkenyl group, a sulfamoyl group, or a heterocyclic residue which may have a substituent selected from the group consisting of a hydroxyl group, methyl group, and alkylthio group; and wherein ○Ce represents a cephalosporin nucleus. .Iaddend.Join the waitlist — get patent alerts
Track USRE33778E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.